Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence. Kurtom S, Liu JB, Doerfler WR, Calcaterra M, et al. Surgery 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Kurtom S, Liu JB, Doerfler WR, Calcaterra M, et al. Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence. Surgery 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.
PMID: 39384477